M&A Deal Summary |
|
|---|---|
| Date | 2024-03-12 |
| Target | Alcresta Therapeutics |
| Sector | Life Science |
| Buyer(s) | Linden Capital Partners |
| Sellers(s) |
Frazier Healthcare Partners
Athyrium Capital Management |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Linden LLC is a private equity firm that invests in businesses involved in the healthcare and life science sectors. However, the firm also executes any size private equity transaction between $10 million to $2 billion through the firm's alliance with Madison Dearborn Partners. Linden is not a venture capital investor. The firm specializes in investments in non-core businesses owned by large corporations, as well as traditional management buyouts of independent companies. Linden LLC was formed in 2004 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 48 of 48 |
| Sector (Life Science) | 10 of 10 |
| Type (Secondary Buyout) | 18 of 18 |
| State (Massachusetts) | 3 of 3 |
| Country (United States) | 47 of 47 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-31 |
Specialty Networks
Cleveland, Ohio, United States Specialty Networks is a technology-enabled group purchasing organization (GPO) that serves independent specialty medical practices, pharmaceutical companies, and medical device companies. Specialty Networks’ service offerings include UroGPO, a urology-specific GPO and provider of educational programs for providers, PPS Analytics, a clinical and business intelligence company serving providers and industry partners, GastroGPO, a gastroenterology-specific GPO, United Rheumatology, a rheumatology-specific GPO, and SN Research, a decentralized clinical research platform. Specialty Networks was founded in 2018 and is headquartered in Cleveland, Ohio. |
Sell | $1.2B |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1991 |
| PE ASSETS | 3.4B USD |
| Size | Large |
| Type | Sector Focused |
Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.
| DEAL STATS | # |
|---|---|
| Overall | 27 of 27 |
| Sector (Life Science) | 10 of 10 |
| Type (Secondary Buyout) | 10 of 10 |
| State (Massachusetts) | 1 of 1 |
| Country (United States) | 27 of 27 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-12 |
RevSpring
Nashville, Tennessee, United States RevSpring is a provider of multi-channel billing and communications solutions to the healthcare and financial services industries. The company helps customers accelerate revenue through an end-to-end platform of offerings that includes physical and electronic invoices, consumer payment portals, data cleansing solutions, and analytics tools that validate consumer identities and optimize engagement. It serves a diversified client base of approximately 2,000 health systems & hospitals, revenue cycle management providers, and financial services organizations. RevSpring was formed in 1997 and is based in Wixom, Michigan. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-06-25 |
BioMatrix Specialty Pharmacy
Plantation, Florida, United States BioMatrix Specialty Pharmacy offers a comprehensive pharmacy with a wide range of services across hemophilia, transplantation, specialty, and digital health technology solutions. BioMatrix Specialty Pharmacy is a provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions. BioMatrix Specialty Pharmacy was founded in 2015 and is based in Plantation, Florida. |
Buy | - |
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 3.7B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 9 |
| Sector (Life Science) | 5 of 5 |
| Type (Secondary Buyout) | 2 of 2 |
| State (Massachusetts) | 1 of 1 |
| Country (United States) | 8 of 8 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-04 |
Lannett Company
Trevose, Pennsylvania, United States Lannett Company is a developer, manufacturer, packager, marketer and distributor of generic pharmaceutical products for a wide range of medical indications. Lannett Company was founded in 1942 and is based in Trevose, Pennsylvania. |
Sell | - |
